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OBJECTIVE: To determine the accuracy of the Mini-Mental State Examination combined with the Verbal Fluency Test and Clock 
Drawing Test for the identification of patients with mild cognitive impairment and Alzheimer’s disease (AD). 
METHOD: These tests were used to evaluate cognitive function in 247 older adults. Subjects were divided into three groups 
according to their cognitive state: mild cognitive impairment (n=83), AD (n=81), cognitively unimpaired controls (n=83), based 
on clinical and neuropsychological data. The diagnostic accuracy of each test for discriminating between these diagnostic groups 
(mild cognitive impairment or AD vs. controls) was examined with the aid of Receiver Operating Characteristic (ROC) curves. 
Additionally, we evaluated the benefit of the combination of tests on diagnostic accuracy. 
RESULTS: Although they were accurate enough for the identification of Alzheimer’s disease, neither test alone proved adequate 
for the correct separation of patients with mild cognitive impairment from healthy subjects. Combining these tests did not improve 
diagnostic accuracy, as compared to the Mini-Mental State Examination alone, in the identification of patients with mild cognitive 
impairment or Alzheimer’s disease. 
CONCLUSIONS: The present data do not warrant the combined use of the Mini-Mental State Examination, the Verbal Fluency 
Test and the Clock Drawing Test as a sufficient diagnostic schedule in screening for mild cognitive impairment. The present data 
do not support the notion that the combination of test scores is better that the use of Mini-Mental State Examination scores alone 
in the screening for Alzheimer’s disease. 
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INTRODUCTION
The term mild cognitive impairment (MCI) refers to 
a transitional state between normal cognitive aging and 
pathological decline, i.e., the propensity to develop incipient 
dementia syndromes. Subjects with MCI are non-demented 
individuals, yet they have demonstrable impairment 
in cognitive functions according to their performance 
on tests adjusted for age and educational level. These 
deficits minimally, if at all, affect the ability to undertake 
activities of daily living.1 Individuals diagnosed with MCI 
have a higher risk for developing dementia, most notably 
Alzheimer’s disease (AD); for this reason, at least a subset 
of MCI patients may in fact represent a prodromal stage of 
AD.2,3 
Despite its clinical importance, the proper identification 
of MCI remains a challenging issue in non-specialized 
settings. The evaluation of patients with MCI usually 
involves a comprehensive neuropsychological assessment, 
along with sophisticated laboratory tests (e.g., analysis of 
cerebrospinal fluid biomarkers) and neuroimaging exams 
(e.g., structural magnetic resonance with volumetric 
measures, functional exams such as SPECT/PET). 
These methods are expensive, need highly specialized 
professionals, and are not routinely available in most clinical 
settings. 
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The majority of cognitive screening tests that are 
commonly used in clinical practice (e.g., the Mini-Mental 
State Examination, the Verbal Fluency Test and the Clock 
Drawing Test), as well as informant-based questionnaires 
(e.g., the Informant Questionnaire of Cognitive Decline 
in the Elderly – IQCODE), have been developed for the 
diagnosis of dementia and are thus not sensitive enough 
to discriminate MCI patients from cognitively unimpaired 
older adults.4,5 As a consequence, a large number of elderly 
subjects with MCI remain unidentified in clinical practice 
in spite of having presented their concerns to the clinician.6 
This challenge is even more difficult to overcome if one 
considers populations with varying degrees of schooling, 
given the relevant education bias that affects most cognitive 
tests. The combination of tests may add diagnostc accuracy 
to cognitive screening. The rationale for this strategy is that 
different tests may provide supplementary information about 
the cognitive functioning of a given patient, increasing the 
probability of identifying those with mild deficits. Several 
different combination strategies may be used, such as 
the “and”/”or” rule and the weighted sum of test scores,7 
which allow the examiner to improve the sensitivity and/or 
specificity of individual tests according to the combination 
rule. Brief cognitive batteries, such as the Cambridge 
Cognitive Test (CAMCOG),8 also lack sensitivity to 
discriminate patients with MCI from cognitively unimpaired 
subjects, in spite of having a better diagnostic accuracy as 
compared to its subcomponents, e.g., the Mini-Mental State 
Examination (MMSE), Verbal Fluency Test (VFT) and Clock 
Drawing Test (CDT).9 In clinical settings, the qualitative 
analysis of the performance in specific cognitive screening 
may help to improve diagnostic accuracy to detect mild but 
relevant deficits.10
Although the combination of screening tests can improve 
the detection of mild to moderate cases of dementia11, few 
data exist about the validity of these instruments for the 
correct identification of elderly persons with MCI. In one 
study, the combination of MMSE and CDT reached good 
sensitivity and specificity values for the multiple-domain 
MCI; however, this combination was not appropriate for 
identifying single-domain (amnestic or non-amnestic) 
MCI subtypes.4,12 In another study, the association of 
an informant-based screening test (the IQCODE) and 
the MMSE showed low sensitivity for screening MCI 
patients, regardless of their subtype5. Few studies have 
been conducted so far with this objective, and there is 
room for several other combinations to be investigated. 
Therefore, the aim of the present study was to determine 
the diagnostic properties of the combination of three widely 
used cognitive screening tests (the MMSE, CDT and VFT) 
to identify subjects with MCI. The tests are timely-effective, 
and their results are easy to interpret. We hypothesized that 
the combination of these instruments may yield a higher 




All subjects included in this analysis are participants 
of an ongoing prospective study on ageing and cognition 
carried out at a specialized memory clinic at the Institute 
of Psychiatry, University of São Paulo, São Paulo, Brazil. 
Recruitment started in June of 2003, and subjects were 
continuously enrolled for cognitive evaluation. Patients and 
controls were recruited from the hospital catchment area 
through information provided by media advertisements and 
lectures about health and aging. We also included subjects 
presenting with spontaneous demand for memory assessment 
and referrals from other medical services. All subjects were 
living in the community at the time of recruitment. This 
study was approved by the local ethics committee and was 
performed in accordance with the Helsinki Declaration. 
For the purpose of this study, we included 247 elderly 
outpatients (73% women) (mean age: 71.3±7.2 years; 
mean educational level: 10.6±5.9 years) with the baseline 
diagnosis of mild cognitive impairment (MCI, n=83), 
Alzheimer’s disease (AD, n=81) and normal cognition 
(controls, n=83).
Assessments
Clinical and neuropsychological evaluations were 
carried out according to a standardized protocol and 
by trained physicians and neuropsychologists. Detailed 
information about the medical evaluation, cognitive and 
neuropsychological assessments, and diagnostic algorithms 
of this cohort can be found elsewhere.13 In brief, the 
cognitive evaluation consisted of the administration of 
the Brazilian version of the Cambridge Examination 
for Mental Disorders in the Elderly (CAMDEX) semi-
structured interview,8,14 which yields scores for the 
Cambridge Cognitive Test (CAMCOG), the Mini-Mental 
State Examination (MMSE)15, and a Verbal Fluency 
Test. The Clock Drawing Test, which is part of the 
CAMCOG schedule, was additionally scored accordingly to 
Sunderland’s guidelines.16 The 21-item Hamilton Depression 
Scale (HAM-D) was administered to all subjects prior to 
neuropsychological assessment in order to rule out the 
presence of clinically relevant depressive symptoms;17 
patients with a HAM-D score of 7 or more were referred to 
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psychiatric attention and not included in the study. 
A comprehensive neuropsychological evaluation 
included the culturally adapted, Brazilian Portuguese 
versions of the following tests: the Rivermead Behavioral 
Memory Test (RBMT) ,18 the Fuld Object-Memory 
Evaluation (FOME),19 a Verbal Fluency Test (category: 
fruits), the Trail Making Test (TMT) A and B20, the 
Short Cognitive Test (SKT),21,22 and the Wechsler Adult 
Intelligence Scale-Revised (WAIS-R) Vocabulary and Block 
Design tests.23 Evidence of functional decline was based 
on the scores of the Informant Questionnaire of Cognitive 
Disorders of the Elderly (IQCODE)24, as well as all available 
evidence concerning difficulties performing basic and 
instrumental activities of daily living, as reported by a close 
relative or caregiver and on the patient’s self-report. 
Clinical diagnosis
Consensus diagnoses were reached at  expert 
multidisciplinary sessions taking into account all information 
about the current medical history and evidence of objective 
cognitive decline as assessed by the neuropsychological 
exams. The scores on the MMSE, VF and CDT were 
obtained at the screening assessment of every patient, and 
this information was not added to the diagnostic protocol. 
Objective cognitive impairment was defined as performance 
below -1.5 standard deviations in the neuropsychological 
evaluation, adjusted by age and educational level in the 
São Paulo elderly population.9,25 Diagnosis of amnestic 
MCI was made according to the following criteria26,27: (1) 
subjective cognitive complaint, preferably corroborated 
by an informant; (2) objective memory impairment in 
the neuropsychological assessment; (3) preserved global 
intellectual function; (4) preserved or minimal impairments 
in activities of daily living; (5) no signs of dementia. 
Diagnosis of Alzheimer’s disease was carried out according 
to established diagnostic criteria28. The control group 
comprised individuals without objective evidence of 
cognitive impairment and subjects with cognitive complaints 
but normal performance in neuropsychological tests (i.e., 
subjective cognitive complainers). 
Statistical analysis
We performed a Pearson’s Chi-square analysis to 
assess the differences in the distribution of gender among 
different diagnostic groups. Kolmogorov-Smirnov tests 
were used to evaluate the normality of the distribution for 
each continuous variable. Since these analyses showed 
that all variables had a normal or near-normal distribution, 
we decided to carry out parametric statistical tests for all 
analyses. For the purpose of this study, we analyzed data 
only for the Mini-Mental State Examination, the Verbal 
Fluency Test and the Clock Drawing Test. We carried out a 
univariate analysis of variance (ANOVA) to assess the mean 
differences for socio-demographic data, clinical variables, 
and scores on cognitive and neuropsychological tests among 
the diagnostic groups. Receiver Operating Characteristic 
(ROC) analyses were performed to calculate the sensitivity, 
specificity and accuracy of the suggested cut-off points 
adjusted by educational level suggestive of cognitive 
impairment proposed by the MMSE (illiterate, < 20, 1 - 4 
years of education, <25, 4 - 8 years of education, <26, 9 
years of education and above, < 28), the VFT (illiterate, 
<10, one year of education and above <14) and the CDT 
(0 - 8 years of education, < 6, above 8 years of education, 
<8)29 to identify MCI or AD cases versus controls. We 
addressed if different combinations of the above mentioned 
tests were more accurate for identifying MCI and AD cases 
in this cohort. Therefore, the following combinations were 
assessed: (1) subjects who scored below the cut-off points 
in the MMSE, the VFT and the CDT were regarded as 
cognitively impaired (the “and” rule); (2) subjects who 
scored below the cut-off points in at least the MMSE, the 
VFT or the CDT were regarded as cognitively impaired (the 
“or” rule); (3) the combination of MMSE and the VFT; (4) 
the combination of the MMSE and CDT, MMSE and VFT 
and the combination of the CDT and VFT. All statistical 
analyses were performed using SPSS v14.0 for Windows 
(SPSS Inc., Chicago, IL), and the α value was set at 5%. 
RESULTS
Demographic and cognitive variables are summarized 
in Table 1. As expected, patients with AD were older, less 
educated and performed worse on the cognitive tests as 
compared to MCI and control individuals (ANOVA, p<.001). 
Subjects with MCI attained intermediate scores on cognitive 
Table 1 - Socio-demographic and cognitive variables in 
control subjects, mild cognitive impairment and Alzheimer’s 
disease patients
Controls MCI AD p
Age (years) 67.8±6.0 70.3±6.1 75.9±7.1 < .001
Education (years) 13.5±5.9 10.0±5.2 8.2±5.4 < .001
MMSE 28.3±1.9 26.8±2.5 19.2±4.8 < .001
CDT 8.9±1.8 7.8±2.1 5.3±2.9 < .001
animal VFT 19.6±4.4 15.6±4.9 10.0±4.7 < .001
MCI = mild cognitive impairment; AD = Alzheimer’s disease; MMSE: 
Mini-Mental State Examination; CDT: Clock Drawing Test; VFT: Verbal 
Fluency Test.
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screening tests (MMSE, CDT and VFT) as compared to AD 
and control individuals. Although significant, the magnitude 
of the difference between subjects with MCI and healthy 
controls on these test scores was small, and scores were 
above the cut-off values that are usually accepted as positive 
screening for dementia.
All tests (separately and in combination) showed good 
accuracy for the identification of AD. The cut-off scores 
of the MMSE alone and the combination of MMSE and 
VFT showed the best accuracy for identifying AD patients 
(Table 2). The MMSE scores alone yielded an area under 
the ROC curve of 0.85 ± 0.03 (p<0.001), indicating the 
best combination of sensitivity and specificity (98% and 
71%, respectively). The “and rule” (i.e., MMSE and CDT 
and VFT scores) had maximum (100%) specificity, and 
the “or rule” (i.e., MMSE or CDT or VFT) had maximum 
sensitivity (100%). However, the AUC obtained from the 
separation of patients with MCI from controls was smaller 
regardless of whether the tests were analyzed separately or 
in combination. All tests alone, the combinations of two 
tests (MMSE + VFT, MMSE + CDT, and VFT + CDT) and 
the “and rule” had good specificity for separating MCI from 
controls, albeit with very low sensitivity. 
DISCUSSION
Our results indicate that the MMSE, the Verbal Fluency 
Test (VFT), and the Clock Drawing Test (CDT) do not have 
a good diagnostic accuracy for identifying cases of MCI, 
in spite of their usefulness in the diagnostic screening for 
dementia. In addition, the combined use of these tests did 
not satisfactorily increase overall diagnostic accuracy when 
separating MCI from controls. Our results are in accordance 
with previous studies from our group and others in which 
the association of cognitive and/or functional tests did not 
provide a good sensitivity in the diagnostic screening for 
MCI.4,5,12 Regarding the identification of cases of dementia 
in this sample, our ROC curves do not demonstrate any 
additional benefit of the combination of tests as compared 
to the analysis of each test score separately. This finding is 
somewhat surprising because other authors have proposed 
that this strategy may improve overall diagnostic accuracy. 
In fact, the present data demonstrate that the combination 
of tests did not __ or minimally, at best __ change diagnostic 
accuracy, as shown by the AUCs. This effect was primarily 
due to the detriment of sensitivity, since specificity was 
substantially increased through a combination of test 
scores. We also observed this phenomenon in the analysis 
of non-demented subjects, where the separation of patients 
with MCI from cognitively healthy controls yielded AUCs 
between 0.5 and 0.6 irrespective of the analysis strategy. In 
other words, the combination of tests substantially reduced 
sensitivity, but it increased specificity up to 97-100%. The 
only exception to this tendency was with the “or rule”, which 
yielded a specificity below 50%.
A few considerations must be made with respect to 
the clinical implications of the present findings. The 
combination of two or three cognitive screening tests is a 
common approach used by physicians to substantiate the 
clinical diagnosis of cognitive impairment, particularly in 
settings where a thorough neuropsychological evaluation is 
not available or because of time constraints. We understand 
that the qualitative observation of the performance on such 
tests, in addition to the score itself, may add important 
insights to the diagnostic workup, as we have previously 
shown that the analysis of MMSE sub-scores supports the 
identification of MCI subtypes10. However, when translating 
this clinical impression into the screening for cognitive 
Table 2 - Diagnostic accuracy of individual tests and their combinations: area under Receiver Operating Characteristic (ROC) 
curves, sensitivity and specificity profiles
MCI vs. Controls AD vs. Controls
AUC Sens. / Specif. AUC Sens. / Specif.
MMSE 0.63 ± 0.04# 54% / 71% 0.85 ± 0.03** 98% / 71%
VFT 0.61 ± 0.04£ 27% / 95% 0.84 ± 0.03** 73% / 95%
CDT 0.59 ± 0.04‡ 30% / 88% 0.74 ± 0.04** 61% / 88%
“and” rule& 0.54 ± 0.05† 9% / 100% 0.74 ± 0.04** 49% / 100%
“or” rule& 0.65 ± 0.04* 73% / 44% 0.78 ± 0.04** 100% / 44%
MMSE + VFT 0.58 ± 0.04 17% / 100% 0.86 ± 0.03** 72% / 100%
MMSE + CDT 0.58 ± 0.04 19% / 97% 0.79 ± 0.04** 61% / 97%
CDT + VFT 0.54 ± 0.05 10% / 100% 0.74 ± 0.04** 49% / 100%
MCI = mild cognitive impairment; AD = Alzheimer’s disease; AUC = Area under the Curve; Sens. = Sensitivity; Specif. = Specificity. &: all tests. MMSE: 
Mini-Mental State Examination; CDT: Clock Drawing Test; VFT: Verbal Fluency Test. * p=0.001; ** p<0.001; # p=0.005; £ p=0.016; ‡ p=0.044; † p>0.05.
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impairment in larger patient groups, we recommend that 
the output of this strategy be interpreted with caution, since 
the combination of test scores according to the “and rule” 
significantly impairs diagnostic sensitivity. In other words, 
caseness will be met only when a given patient shows 
abnormal performance on all tests utilized for assessment. 
This strategy will deliver a high number of false negative 
cases that correspond to patients who in fact have subtle 
abnormalities that might have been detected by one single 
test. On the other hand, the specificity of estimates based on 
the “and rule” will be significantly increased in the presence 
of abnormal performance in all tests together. 
Brief cognitive tests are developed to provide good 
sensitivity in the screening for dementia, whereas specificity 
is usually attained with more inclusive batteries or through 
formal neuropsychological evaluation. Specificity can be 
further increased by adding information from laboratory 
and neuroimaging tests, both for the purpose of ruling out 
comorbidities that concur with a high prevalence of cognitive 
impairment30 and to ascertain underlying pathological 
features of AD31. The complexity of this procedure is a 
limitation for the large-scale diagnosis of MCI, particularly 
in primary care settings. The basic purpose of the tests that 
we addressed in this study (i.e., good for screening) was met 
by all three tests when the target was identifying dementia 
(AD), but not when attempting to detect subtle deficits (i.e., 
MCI). One possible explanation is that these tests are prone 
to ceiling effects, particularly among more educated MCI 
patients. In other words, subjects with mild deficits may still 
be able to perform well in spite of the existence of symptoms 
compatible with incipient AD32. Since most available 
cognitive screening tests have been developed to separate 
dementia from non-dementia, the development of new tests 
specially designed to screen for mild cognitive deficits, such 
as the Montreal Cognitive Assessment (MoCA)33 and the 
Computer-assisted Neuropsychological Screening for MCI 
(CANS-MCI),34 may overcome this limitation. In addition, 
the combination of cognitive tests and functional scales, 
or functional scales alone, may serve as alternatives for 
screening subjects with cognitive complaints. Bottino et 
al.35 found that the association of FOME and MMSE with 
two informant-based functional scales (IQCODE and Bayer 
Activities of Daily Living Scale) was sensitive enough to 
identify cases with mild to moderate dementia. Perroco 
and colleagues36 recently reported that the IQCODE (and 
its shorter version) was also sensitive enough to screen 
for patients with mild dementia. The objective functional 
assessment, as provided by the DAFS (Direct Assessment of 
Functional State), discriminated MCI patients from patients 
with dementia with high accuracy; nonetheless, it had a 
lower accuracy for discriminating patients with MCI from 
cognitively unimpaired elderly subjects37. Therefore, despite 
the fact that several screening strategies may be useful for 
the identification of mild to moderate dementia cases, there 
is still a long road ahead when addressing the screening for 
pre-dementia cases. 
The sample of patients and controls on which the 
present analysis was based has certain characteristics that 
may explain the discrepancy between our findings and 
previous notions that supported the advantage of combining 
tests. First, the AD patients included in this study had 
mild or incipient dementia, as opposed the predominance 
of patients with mild to moderate dementia in previous 
studies, rendering patients in our AD group less impaired 
and narrowing the difference between their mean scores 
and those obtained by patients in the comparison groups 
(MCI and controls). Conversely, our controls are not only 
non-demented but also cognitively unimpaired, since we 
separated cognitively healthy subjects (controls) from 
those with MCI through a neuropsychological assessment. 
Most studies conducted in the late 1980s and 1990s did not 
separate these two states, leading to contamination of the 
control group with subtle forms of cognitive impairment; 
in this case, the scores obtained by historical controls 
tend to be lower than the ones observed in our sample. In 
both instances (i.e., less impaired AD patients and above 
average controls), the range of cognitive deficits will be 
smaller, affecting the cut-off scores that best separate 
groups. We understand that educational level is an important 
issue when assessing patients with cognitive complaints/
impairment, particularly in populations with heterogeneous 
backgrounds. In this analysis, we controlled for this effect 
by using different cut-off scores for the cognitive screening 
tests, which have been established for the Brazilian 
population.29 In addition, the clinical diagnoses provided 
by the multidisciplinary expert consensus meeting yield 
important insights as to whether any given finding is 
clinically relevant or not. 
CONCLUSION
The present results highlight three important issues that 
have practical implications for the diagnostic workup of 
cognitive disorders. First, the MMSE alone may be sufficient 
in the screening for dementia, since the combinations of 
tests did not increase diagnostic accuracy. Second, the 
combination of the MMSE, the VFT and the CDT (by means 
of several different analytical strategies) did not accurately 
identify cases of MCI in a clinical setting. Finally, the 
diagnosis of MCI still depends on the information provided 
by a comprehensive neuropsychological assessment. 
Alternatively, the clinical evaluation along with other 
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supportive diagnostic techniques, such as the measurement 
of AD-related biomarkers in cerebrospinal fluid and/or 
structural and functional neuroimaging, may be necessary to 
substantiate the diagnosis of MCI and the subsequent risk of 
developing AD.39-41 Of course, these resources are restricted 
to specialized settings and are not appropriate for large-scale 
screening of cognitive impairment. From the clinician’s 
perspective, the identification of patients with MCI, as well 
as the evaluation of the risk for progression to dementia, 
still relies on careful clinical judgment and the longitudinal 
determination of cognitive status with the available tools.42
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